LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Avalo Therapeutics (NASDAQ: AVTX)

Follow NASDAQ:AVTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ AVTX Avalo Therapeutics
Persson Magnus / director
12/20/2023
Buy
$0.04
3,334
$143
3,334
NASDAQ AVTX Avalo Therapeutics
Almenoff June Sherie / director
12/20/2023
Buy
$0.04
3,334
$143
3,334
NASDAQ AVTX Avalo Therapeutics
KAPLAN GILLA / director
12/20/2023
Buy
$0.04
3,334
$143
3,334
NASDAQ AVTX Avalo Therapeutics
Chan Mitchell / director
12/20/2023
Buy
$0.04
3,334
$143
3,334
NASDAQ AVTX Avalo Therapeutics
Persson Magnus / director
06/30/2023
Buy
$0.36
28,308
$10K
28,308
NASDAQ AVTX Avalo Therapeutics
Almenoff June Sherie / director
06/30/2023
Buy
$0.36
4,575
$2K
4,575
NASDAQ AVTX Avalo Therapeutics
ARMISTICE CAPITAL, LLC / 10 percent owner
06/26/2023
Sell
$0.61
2.75M
$1.682M
1.67M
NASDAQ AVTX Avalo Therapeutics
ARMISTICE CAPITAL, LLC / 10 percent owner
06/27/2023
Sell
$0.52
937,404
$487K
731,458
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/26/2023
Sell
$0.62
182,300
$113K
0
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/26/2023
Sell
$0.64
1.43M
$917K
0
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/20/2023
Buy
$4.14
2,000
$8K
1.43M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/16/2023
Buy
$3.90
3,000
$12K
1.42M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/15/2023
Buy
$3.68
3,160
$12K
1.42M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/14/2023
Buy
$3.48
6,000
$21K
1.42M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/13/2023
Buy
$3.82
8,750
$33K
1.41M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/12/2023
Buy
$4.34
2,149
$9K
1.40M
NASDAQ AVTX Avalo Therapeutics
Sullivan Christopher Ryan / officer: Chief Financial Officer
06/09/2023
Buy
$3.42
511
$2K
1,262
NASDAQ AVTX Avalo Therapeutics
NEIL GARRY ARTHUR / director, officer: CEO and Chairman of the Board
06/09/2023
Buy
$3.42
4,000
$14K
13,220
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/09/2023
Buy
$4.14
5,044
$21K
1.40M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/08/2023
Buy
$3.93
6,398
$25K
1.40M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
06/07/2023
Buy
$3.49
2,984
$10K
1.39M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/31/2023
Buy
$2.87
844
$2K
1.39M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/30/2023
Buy
$2.87
671
$2K
1.39M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/25/2023
Buy
$2.77
2,000
$6K
1.38M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/24/2023
Buy
$2.96
5,519
$16K
1.38M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/24/2023
Buy
$3.01
3,481
$10K
1.38M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/22/2023
Buy
$3.34
7,000
$23K
1.37M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/19/2023
Buy
$3.52
6,500
$23K
1.37M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/18/2023
Buy
$3.29
13,121
$43K
1.36M
NASDAQ AVTX Avalo Therapeutics
Sullivan Christopher Ryan / officer: Chief Financial Officer
05/15/2023
Buy
$2.75
40,000
$110K
40,000
NASDAQ AVTX Avalo Therapeutics
NEIL GARRY ARTHUR / director, officer: CEO and Chairman of the Board
05/15/2023
Buy
$2.75
100,000
$275K
100,000
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/16/2023
Buy
$2.75
379
$1K
1.35M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/15/2023
Buy
$2.55
1,715
$4K
1.35M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/12/2023
Buy
$2.45
2,285
$6K
1.34M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/08/2023
Buy
$2.62
5,000
$13K
1.34M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/05/2023
Buy
$2.88
5,000
$14K
1.34M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
05/04/2023
Buy
$2.79
15,000
$42K
1.33M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
04/27/2023
Buy
$2.96
1,504
$4K
1.32M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
04/26/2023
Buy
$2.97
425
$1K
1.32M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
04/25/2023
Buy
$3.00
5,571
$17K
1.32M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
04/24/2023
Buy
$3.06
12,500
$38K
1.31M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
04/20/2023
Buy
$3.08
5,000
$15K
1.30M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
04/18/2023
Buy
$2.94
10,000
$29K
1.29M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
04/17/2023
Buy
$2.96
15,000
$44K
1.28M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
04/11/2023
Buy
$2.84
25,000
$71K
1.27M
NASDAQ AVTX Avalo Therapeutics
Caissa Capital Management ltd. / 10 percent owner
04/10/2023
Buy
$2.28
31,329
$71K
1.24M
NASDAQ AVTX Avalo Therapeutics
Almenoff June Sherie / director
03/31/2023
Buy
$1.75
1,167
$2K
1,167
NASDAQ AVTX Avalo Therapeutics
Persson Magnus / director
03/31/2023
Buy
$1.75
7,222
$13K
7,222
NASDAQ AVTX Avalo Therapeutics
Sullivan Christopher Ryan / officer: Chief Financial Officer
02/13/2023
Buy
$2.98
40,000
$119K
40,000
NASDAQ AVTX Avalo Therapeutics
NEIL GARRY ARTHUR / director, officer: CEO and Chairman of the Board
02/13/2023
Buy
$2.98
100,000
$298K
100,000
NASDAQ AVTX Avalo Therapeutics
ARMISTICE CAPITAL, LLC / 10 percent owner
02/07/2023
Buy
$3.98
450,000
$1.791M
4.42M
NASDAQ AVTX Avalo Therapeutics
ARMISTICE CAPITAL, LLC / 10 percent owner
02/03/2023
Buy
$3.95
334
$1K
3.97M
NASDAQ AVTX Avalo Therapeutics
ARMISTICE CAPITAL, LLC / 10 percent owner
02/07/2023
Buy
$5.00
450,000
$2.250M
450,000
NASDAQ AVTX Avalo Therapeutics
NEIL GARRY ARTHUR / officer: CEO and Chairman of the Board
12/09/2022
Buy
$4.42
2,083
$9K
9,220
NASDAQ AVTX Avalo Therapeutics
Persson Magnus / director
06/30/2022
Buy
$0.50
26,837
$13K
26,837
NASDAQ AVTX Avalo Therapeutics
KAPLAN GILLA / director
06/30/2022
Buy
$0.50
44,115
$22K
44,115
NASDAQ AVTX Avalo Therapeutics
Almenoff June Sherie / director
06/30/2022
Buy
$0.50
4,338
$2K
4,338
NASDAQ AVTX Avalo Therapeutics
Persson Magnus / director
06/14/2022
Buy
$0.44
40,000
$18K
40,000
NASDAQ AVTX Avalo Therapeutics
KAPLAN GILLA / director
06/14/2022
Buy
$0.44
40,000
$18K
40,000
NASDAQ AVTX Avalo Therapeutics
Chan Mitchell / director
06/14/2022
Buy
$0.44
40,000
$18K
40,000
NASDAQ AVTX Avalo Therapeutics
Almenoff June Sherie / director
06/14/2022
Buy
$0.44
40,000
$18K
40,000

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous